Smart Omix Blog

Written for researchers, by researchers

What is study adherence?
What is study adherence?
Jul 28, 2022 4:57:44 PM

Studies have shown that adherence to intervention protocols is higher in clinical trials than in non-research settings. ...

Reimagining the traditional electronic patient-reported outcome (ePRO)
Reimagining the traditional electronic patient-reported outcome (ePRO)
Jul 28, 2022 4:21:33 PM

Electronic Patient-Reported Outcomes (ePROs) have been a crucial development in clinical research in the last decade. Ta...

Nutraceutical Marketing
Nutraceutical Marketing
Jul 25, 2022 1:57:00 PM

Nutraceutical Marketing: Show me the proof! Standing out in the crowd while adhering to industry regulations If you’ve r...

Don't You Forget About Me: Nutraceuticals
Don't You Forget About Me: Nutraceuticals
Jul 25, 2022 1:46:54 PM

The demand for health products and services has never been greater, and the average consumer is growing increasingly sav...

eConsent explained
eConsent explained
Jun 29, 2022 12:43:08 PM

As defined by the Food and Drug Administration, eConsent refers to “the use of electronic systems and processes that may...

PGHD for Digital Phenotyping and Digital Biomarker Development
PGHD for Digital Phenotyping and Digital Biomarker Development
Jun 22, 2022 3:02:25 PM

Last month, UCB, held its first Digital Health Roundtable on Leveraging Patient-Generated Health Data for Digital Phenot...

What is PGHD?
What is PGHD?
Jun 20, 2022 3:04:28 PM

What is PGHD? PGHD is defined by the US Office of the National Coordinator for Health Information Technology (ONC), pati...

doc.ai joins Sharecare
doc.ai joins Sharecare
Feb 23, 2021 6:38:10 AM

We all have our own healthcare story - whether managing a chronic condition or helping a loved one navigate an illness. ...

doc.ai to be acquired by Sharecare
doc.ai to be acquired by Sharecare
Jan 28, 2021 9:13:00 AM

Today, I’m excited to share that doc.ai has entered into a definitive agreement to be acquired by Sharecare, the digital...

doc.ai and UCB biopharma team up to develop breakthrough AI models to advance care
doc.ai and UCB biopharma team up to develop breakthrough AI models to advance care
Nov 19, 2020 6:23:53 AM

Today we’re excited to announce a new collaboration with UCB, a multinational biopharma company headquartered in Brussel...

Categories